Spero Therapeutics, Inc. Share Price Börse Stuttgart
Stocks
2HA
US84833T1034
Biotechnology & Medical Research
|
Market Closed -
Börse Stuttgart
20:55:14 09/10/2026 BST
|
5-day change | 1st Jan Change | ||
| 1.056 EUR | +5.28% |
|
-9.96% | -47.38% |
| 08-12 | Spero Therapeutics, Inc., Q2 2026 Earnings Call, Aug 12, 2026 | |
| 08-12 | Spero Therapeutics, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2026 | CI |
| Market Cap | 69.88M 62.41M 58.06M 52.81M 99.71M 6.76B 100M 699M 274M 3.45B 262M 257M 11.07B | P/E 2026 * |
-2.07x | P/E 2027 * | -11.4x |
|---|---|---|---|---|---|
| Enterprise Value | 69.88M 62.41M 58.06M 52.81M 99.71M 6.76B 100M 699M 274M 3.45B 262M 257M 11.07B | EV / Sales 2026 * |
271x | EV / Sales 2027 * | - |
| Free-Float |
77.34% | Yield 2026 * |
-
| Yield 2027 * | - |
| Markets | Quality | ||
|---|---|---|---|
Nasdaq
| SPRO | Delayed | |
CBOE
| SPRO | Real-time | |
|
Tradegate
| 2HA | Real-time | |
|
Boerse Muenchen
| 2HA | Real-time | |
|
Deutsche Boerse AG
| 2HA | Delayed | |
|
Börse Stuttgart
| 2HA | Delayed |
Last Transcript: Spero Therapeutics, Inc.
| 1 week | +0.67% | ||
| Current month | -0.47% | ||
| 1 month | +5.49% | ||
| 3 months | -42.98% | ||
| 6 months | -55.10% | ||
| Current year | -44.60% |
| 1 week | 1 |  | 1.08 |
| 1 month | 0.95 | | 1.22 |
| 3 years | 0.49 | | 2.6 |
| 5 years | 0.49 | | 15.6 |
| Manager | Title | Age | Since |
|---|---|---|---|
Esther Rajavelu
CEO | Chief Executive Officer | 47 | 09/01/2025 |
Debra Zack
CTO | Chief Tech/Sci/R&D Officer | 69 | 26/07/2026 |
Timothy Keutzer
COO | Chief Operating Officer | 58 | 31/01/2023 |
| Director | Title | Age | Since |
|---|---|---|---|
Milind Deshpande
CHM | Chairman | 69 | 31/12/2013 |
| Director/Board Member | 62 | 31/08/2015 | |
Frank Thomas
CHM | Chairman | 56 | 09/01/2025 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +5.28% | -9.96% | -44.94% | -0.19% | 66.39M | |
| -2.59% | -5.70% | +39.83% | +82.45% | 72.13B | |
| +3.23% | -10.67% | +4.87% | +55.97% | 49.41B | |
| +1.56% | +1.17% | +5.15% | +33.38% | 47.24B | |
| +0.39% | +0.65% | +28.02% | +30.24% | 42.61B | |
| +0.87% | -8.17% | +298.53% | +645.03% | 40.32B | |
| +1.24% | -1.01% | +5.56% | +105.14% | 39.81B | |
| -2.13% | -1.64% | +7.51% | +50.31% | 30.52B | |
| -0.46% | -1.28% | +31.47% | +19.93% | 28.29B | |
| +5.32% | +0.06% | -7.20% | -11.30% | 23.13B | |
| Average | +0.83% | -2.97% | +36.88% | +101.10% | 41.5B | |
| Weighted average by Cap. | +0.52% | -3.18% | +47.54% | +116.76% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 258K 230K 214K 195K 368K 24.97M 370K 2.58M 1.01M 12.73M 969K 948K 40.85M | - |
| Net income | -33.46M -29.88M -27.79M -25.28M -47.73M -3.24B -47.94M -335M -131M -1.65B -126M -123M -5.3B | -51.5M -45.99M -42.79M -38.92M -73.48M -4.98B -73.8M -515M -202M -2.54B -193M -189M -8.15B |
| Net Debt | - | - |
| Date | Price | Change |
|---|---|---|
| 09/10/26 | €1.056 | +5.28% |
| 08/10/26 | €1.003 | -2.53% |
| 07/10/26 | €1.029 | -1.15% |
| 06/10/26 | €1.041 | +1.36% |
| 05/10/26 | €1.027 | -2.10% |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- SPRO Stock
- 2HA Stock
Select your edition
All financial news and data tailored to specific country editions
